Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Strepsils throat lozenges available in handy tube

Reckitt Benckiser is introducing its Strepsils lozenges for sore throat relief in convenient new tube packaging. Strepsils Handy Tubes are available in Honey & Lemon and Cool flavours.


The compact pack is designed to be sold in tandem with traditional blister packs, but has been developed to sit alongside medicinal confectionery as a front of counter product, says Reckitt Benckiser.


“Strepsils Handy Tubes have been developed specifically for independent retailers and pharmacies,” comments Stefan Gaa, the company’s marketing director.


The launch will be supported by a £4 million national TV, radio and bus advertising campaign which starts this month. The bus advertising is targeted at commuters.Sampling activity is planned for Strepsils Cool and point of sale material is available for pharmacies.


Prices and Pip codes: Honey & Lemon £1.46/10, 347-2586; Cool £1.95/10, 347-2602Reckitt BenckiserTel: 01482 326151

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD011854

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel